ArticlePloS one2025

Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach.

Robert S Leigh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.